Terms: = Ovarian cancer AND ERG, P11308, 2078
22 results:
1. Endoplasmic Reticulum Stress-Related Ten-Biomarker Risk Classifier for Survival Evaluation in Epithelial ovarian cancer and
Zhang M; Wang Y; Xu S; Huang S; Wu M; Chen G; Wang Y
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762313
[TBL] [Abstract] [Full Text] [Related]
2. Molecular basis and therapeutic targets in prostate cancer: A comprehensive review.
Militaru FC; Militaru V; Crisan N; Bocsan IC; Udrea AA; Catana A; Kutasi E; Militaru MS
Biomol Biomed; 2023 Sep; 23(5):760-771. PubMed ID: 37021836
[TBL] [Abstract] [Full Text] [Related]
3. Endometrial giant cell carcinoma: new insights from a morphological, immunohistochemical, and molecular analysis of three cases.
Arciuolo D; Travaglino A; Raffone A; Santoro A; Russo G; Minucci A; Inzani F; Mollo A; Pedone Anchora L; Fanfani F; Insabato L; Zannoni GF
Virchows Arch; 2022 Aug; 481(2):321-326. PubMed ID: 35305145
[TBL] [Abstract] [Full Text] [Related]
4. Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor.
Ye H; Lin M; Li R; Qin S; Hou G; Chen H; Li X
J Ovarian Res; 2021 Jan; 14(1):21. PubMed ID: 33509230
[TBL] [Abstract] [Full Text] [Related]
5. Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Fumet JD; Limagne E; Thibaudin M; Truntzer C; Bertaut A; Rederstorff E; Ghiringhelli F
BMC Cancer; 2020 Aug; 20(1):748. PubMed ID: 32778095
[TBL] [Abstract] [Full Text] [Related]
6. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
7. Unilateral cancer-associated retinopathy: diagnosis, serology and treatment.
Roels D; Ueno S; Talianu CD; Draganova D; Kondo M; Leroy BP
Doc Ophthalmol; 2017 Dec; 135(3):233-240. PubMed ID: 28815346
[TBL] [Abstract] [Full Text] [Related]
8. Angiosarcoma of the Pelvis in a 13-Year-Old Girl.
El-Sharkawy F; Delgado PI; Podda A; Neville HL; Rojas CP
Pediatr Dev Pathol; 2017; 20(2):163-167. PubMed ID: 28326959
[TBL] [Abstract] [Full Text] [Related]
9. PAX8-positive Biphasic Synovial Sarcoma Expressing Hormonal Receptors.
Lordello L; Bur ME; Oliva E; Lennerz JK
Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):e71-e74. PubMed ID: 28248726
[TBL] [Abstract] [Full Text] [Related]
10. Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive ovarian, Fallopian Tube and Peritoneal cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Tappenden P; Harnan S; Ren S; Thokala P; Wong R; Mukuria C; Green C; Pledge S; Tidy J
Pharmacoeconomics; 2017 Jan; 35(1):97-109. PubMed ID: 27506954
[TBL] [Abstract] [Full Text] [Related]
11. ovarian Hemangiomas Do Not Harbor EWSR1 Rearrangements: Clinicopathologic Characterization of 10 Cases.
Schoolmeester JK; Greipp PT; Keeney GL; Soslow RA
Int J Gynecol Pathol; 2015 Sep; 34(5):437-44. PubMed ID: 25851709
[TBL] [Abstract] [Full Text] [Related]
12. Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ergs.
Ueno S; Nakanishi A; Nishi K; Suzuki S; Terasaki H
Doc Ophthalmol; 2015 Feb; 130(1):71-6. PubMed ID: 25391361
[TBL] [Abstract] [Full Text] [Related]
13. Low frequency of ESRRA-C11orf20 fusion gene in ovarian carcinomas.
Micci F; Panagopoulos I; Thorsen J; Davidson B; Tropé CG; Heim S
PLoS Biol; 2014 Feb; 12(2):e1001784. PubMed ID: 24504521
[TBL] [Abstract] [Full Text] [Related]
14. Differentially methylated loci distinguish ovarian carcinoma histological types: evaluation of a DNA methylation assay in FFPE tissue.
Kelemen LE; Köbel M; Chan A; Taghaddos S; Dinu I
Biomed Res Int; 2013; 2013():815894. PubMed ID: 24175302
[TBL] [Abstract] [Full Text] [Related]
15. Trabectedin for the treatment of relapsed ovarian cancer.
Papaioannou D; Rafia R; Stevenson MD; Stevens JW; Evans P
Health Technol Assess; 2011 May; 15 Suppl 1():69-75. PubMed ID: 21609655
[TBL] [Abstract] [Full Text] [Related]
16. The oncogenic gene fusion TMPRSS2: erg is not a diagnostic or prognostic marker for ovarian cancer.
Huang L; Schauer IG; Zhang J; Mercado-Uribe I; Deavers MT; Huang J; Liu J
Int J Clin Exp Pathol; 2011; 4(7):644-50. PubMed ID: 22076164
[TBL] [Abstract] [Full Text] [Related]
17. [Borderline ovarian tumors and global radiation in relation with climate change impact].
Luchian AM; Pricop M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):813-9. PubMed ID: 22046792
[TBL] [Abstract] [Full Text] [Related]
18. Borderline ovarian mucinous neoplasm recurring as small cell carcinoma of hypercalcemic type: evidence for an epithelial histogenesis and relationship with ovarian mucinous tumors for this enigmatic neoplasm.
Mansor S; Nagarajan S; Sumathi VP; McCluggage WG
Int J Gynecol Pathol; 2011 Jul; 30(4):380-5. PubMed ID: 21623206
[TBL] [Abstract] [Full Text] [Related]
19. The oncogenic role of the ETS transcription factors MEF and erg.
Sashida G; Bazzoli E; Menendez S; Liu Y; Nimer SD
Cell Cycle; 2010 Sep; 9(17):3457-9. PubMed ID: 20814243
[TBL] [Abstract] [Full Text] [Related]
20. cancer-associated retinopathy with retinal periphlebitis in a patient with ovarian cancer.
Kim SJ; Toma HS; Thirkill CE; Dunn JP
Ocul Immunol Inflamm; 2010 Apr; 18(2):107-9. PubMed ID: 20370338
[TBL] [Abstract] [Full Text] [Related]
[Next]
